This Philly company raised $2M. Here's how its founder won over the skeptics - Technical.ly Philly

Sciences

Nov. 5, 2018 11:41 am

This Philly company raised $2M. Here’s how its founder won over the skeptics

Group K Diagnostics said the $2 million Series A will let it expand its lab and manufacturing space as it continues work on its rapid diagnostics device.

Brianna Wronko, Group K Diagnostics founder.

(Courtesy photo)

The initial resistance Group K Diagnostics felt among investors seems to be dissipating.

Though at first the Theranos scandal haunted founder Brianna Wronko in the pitch room — one investor even likening her to Theranos CEO Elizabeth Holmes — the founder and CEO says promising results in clinical trials have turned investors onto backing her startup.

On Monday, the company announced it had secured a $2 million Series A aimed at scaling up production, commercialization and regulatory processes for its technology. The funding was led by “a private holding company that asked not to be named,” Wronko said, but like most investors in the round, the firm had previously backed its seed round.

“This was a huge show of support,” said Wronko, who expects the company to be in a new lab space near Jefferson’s campus on 1015 Chestnut St. by January 1. “This is growing us from a small startup to a decent-sized company.”

Group K manufactures a point-of-care testing device for the healthcare space. With a test strip that uses microfluidics technology, a few drops from patient’s blood can be analyzed by a mobile app and yield faster results than traditional analysis. The device and technology, Wronko said, are expected to receive clearance from the Food and Drug Administration by June of next year.

Currently a team of 14 split between Philly and India, the company expects to be at 26 by March next year.

Wronko said it’s the results of the trial, and their transparency toward investors, which have dissipated early skepticism around the company’s technology.

“These are investors who have seen our tech,” the founder and University of Pennsylvania grad said. “We’ve shown them our entire process and we’ve continually given the message that we’re based on science. That’s what’s made a difference. People aren’t comparing us anymore because there wasn’t any technology behind them.”

The Holmes references, she said, have also stopped.

“That’s gone,” Wronko said. “I even have a black T-shirt on today.”

-30-
JOIN THE COMMUNITY, BECOME A MEMBER
Already a member? Sign in here

Advertisement

Old City medtech startup Strados Labs set to hire after raising $1.8M

Biotech company Chondrial Therapeutics has raised $25.8M for its Friedreich’s ataxia treatment

First Round Capital has a big pay day as Uber goes public

SPONSORED

Philly

Why working with the University City Science Center was a game changer for 4 Philly startups

Philadelphia, Pa

Inspire

Event Sales Ambassador

Apply Now
Philadelphia, PA

PromptWorks

Director of Product Design

Apply Now
Philadelphia

Perpay

UX Designer

Apply Now

This precision medicine company just raised $5M to help save preemies

Roundtrip just raised a $5.1M Series A to double in size

HealthVerity plans big growth spurt with $25M Series C

SPONSORED

Philly

Take a peek at the opportunities popping up at PromptWorks

Chesterbrook, PA

Deacom

Inside Sales Representative

Apply Now
Horsham, PA

Penn Mutual

Software Engineer-Java

Apply Now
Ambler, PA

IntegriChain

Data Engineer

Apply Now

Sign-up for daily news updates from Technical.ly Philadelphia

Do NOT follow this link or you will be banned from the site!